173 related articles for article (PubMed ID: 12040285)
1. Chemotherapy for advanced thymic carcinoma: clinical response to cisplatin, doxorubicin, vincristine, and cyclophosphamide (ADOC chemotherapy).
Koizumi T; Takabayashi Y; Yamagishi S; Tsushima K; Takamizawa A; Tsukadaira A; Yamamoto H; Yamazaki Y; Yamaguchi S; Fujimoto K; Kubo K; Hirose Y; Hirayama J; Saegusa H
Am J Clin Oncol; 2002 Jun; 25(3):266-8. PubMed ID: 12040285
[TBL] [Abstract][Full Text] [Related]
2. [ADOC regimen for unresectable advanced thymic cancer].
Koizumi T; Takabayashi Y; Yamagishi S; Tsushima K; Takamizawa A; Takashi S; Tsukadaira A; Masubuchi T; Yamamoto H; Kaneki T; Yamaguchi S; Hachiya T; Hayasaka M; Fujimoto K; Kubo K
Nihon Kokyuki Gakkai Zasshi; 1999 Dec; 37(12):970-3. PubMed ID: 10707536
[TBL] [Abstract][Full Text] [Related]
3. Second-line chemotherapy of platinum compound plus CPT-11 following ADOC chemotherapy in advanced thymic carcinoma: analysis of seven cases.
Kanda S; Koizumi T; Komatsu Y; Yoshikawa S; Okada M; Hatayama O; Yasuo M; Tsushima K; Urushihata K; Kubo K; Sasabayashi M; Takamizawa A
Anticancer Res; 2007; 27(4C):3005-8. PubMed ID: 17695487
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with doxorubicin, vincristine, cyclophosphamide, and platinum compounds for advanced thymic carcinoma.
Agatsuma T; Koizumi T; Kanda S; Ito M; Urushihata K; Yamamoto H; Hanaoka M; Kubo K
J Thorac Oncol; 2011 Dec; 6(12):2130-4. PubMed ID: 21892103
[TBL] [Abstract][Full Text] [Related]
5. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.
Yoh K; Goto K; Ishii G; Niho S; Ohmatsu H; Kubota K; Kakinuma R; Nagai K; Suga M; Nishiwaki Y
Cancer; 2003 Sep; 98(5):926-31. PubMed ID: 12942558
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients.
Berruti A; Borasio P; Roncari A; Gorzegno G; Mossetti C; Dogliotti L
Ann Oncol; 1993 May; 4(5):429-31. PubMed ID: 8353078
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature.
Kitami A; Suzuki T; Kamio Y; Suzuki S
Jpn J Clin Oncol; 2001 Dec; 31(12):601-4. PubMed ID: 11902491
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of invasive thymoma.
Fornasiero A; Daniele O; Ghiotto C; Sartori F; Rea F; Piazza M; Fiore-Donati L; Morandi P; Aversa SM; Paccagnella A
J Clin Oncol; 1990 Aug; 8(8):1419-23. PubMed ID: 2380761
[TBL] [Abstract][Full Text] [Related]
9. [Successful treatment of intrapericardial administration of carboplatin following systemic chemotherapy in a case of advanced thymic cancer with cardiac tamponade].
Okada M; Koizumi T; Yasuo M; Tsushima K; Urushihata K; Yamaguchi S; Hanaoka M; Fujimoto K; Kubo K
Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):968-72. PubMed ID: 17233396
[TBL] [Abstract][Full Text] [Related]
10. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for invasive thymoma. A 13-year experience.
Fornasiero A; Daniele O; Ghiotto C; Piazza M; Fiore-Donati L; Calabró F; Rea F; Fiorentino MV
Cancer; 1991 Jul; 68(1):30-3. PubMed ID: 2049749
[TBL] [Abstract][Full Text] [Related]
12. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
[TBL] [Abstract][Full Text] [Related]
13. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.
Berruti A; Borasio P; Gerbino A; Gorzegno G; Moschini T; Tampellini M; Ardissone F; Brizzi MP; Dolcetti A; Dogliotti L
Br J Cancer; 1999 Nov; 81(5):841-5. PubMed ID: 10555755
[TBL] [Abstract][Full Text] [Related]
14. Metastatic thymic epithelial tumors: A regional cancer center experience.
Lakshmaiah KC; Chaudhuri T; Babu GK; Dasappa L; Jacob LA; Babu MCS; Rudresha AH; Lokesh KN; Rajeev LK
Indian J Cancer; 2018; 55(3):288-291. PubMed ID: 30693896
[TBL] [Abstract][Full Text] [Related]
15. [Complete resection for giant thymic carcinoma after simultaneous combination chemotherapy].
Ueki T; Ueshima Y; Kurioka H; Enoki Y; Hosokawa Y
Kyobu Geka; 2005 Apr; 58(4):320-3. PubMed ID: 15828254
[TBL] [Abstract][Full Text] [Related]
16. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
[TBL] [Abstract][Full Text] [Related]
17. Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
Berruti A; Tampellini M; Gorzegno G; Dogliotti L
Chest; 1997 May; 111(5):1473-4. PubMed ID: 9149629
[No Abstract] [Full Text] [Related]
18. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
19. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.
Loehrer PJ; Chen M; Kim K; Aisner SC; Einhorn LH; Livingston R; Johnson D
J Clin Oncol; 1997 Sep; 15(9):3093-9. PubMed ID: 9294472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
